Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  IGF-1R antisense oligodeoxynucleotide-treated autologous glioma cells
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
IGF-1R/AS ODN-Treated Tumor Cells in Treating Patients with Malignant Glioma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14G.96, NCI-2015-01499, 14379-102, 2009-40, 2014-008, 2405, TJU-14379-102, NCT02507583
Start Over